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INTRODUCTION:  Cutaneous  extramedullary  plasmacytoma  without  bone  marrow  involvement  is  very
rare. We  present  a plasmacytoma  on  the scalp  with  an  adjacent  Bowenoid  disease.
PRESENTATION:  An  86  year  old man  presented  to  our  unit  with  an  ulcerated  lump  on  the  vertex  of  the
scalp.  Excisional  biopsy  showed  plasmacytoma  with  adjacent  Bowenoid  actinic  keratosis.  Blood  tests  did
not show  any  systemic  multiple  myeloma.  However,  skeletal  survey  showed  possible  osteolytic  lesions




DISCUSSION:  As  far  as  we  know,  this  is  the  ﬁrst reported  case  of a cutaneous  plasma  cell  tumour  next  to
an area  of  Bowenoid  actinic  keratosis.  Relevant  literature  is investigated  here  for possible  correlation.
CONCLUSION:  Within  the  limitations  of  this  study,  solitary  primary  cutaneous  plasmacytoma  can  be
treated  surgically  with  a  favourable  outcome.  A hypothesis  of  correlation  between  Bowenoid  actinic
keratosis  and plasmacytoma  is  investigated  here.  Further  research  is  needed  to  conﬁrm  this  ﬁnding.
© 2016  The  Authors.  Published  by  Elsevier  Ltd.  on behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Case report
We  present an 86 year old man, who had a sore, weeping and
apidly growing ulcerated plaque on the vertex of the scalp. Oth-
rwise the patient was well in himself without any weight loss
r night sweating. Past medical history includes hypercholestro-
aemia for which he is on statins. He denies smoking or drinking
lcohol. There is no family history of any blood disorders.
On presentation, there was a 2.0 cm ulcerated lump on the ver-
ex of the scalp. There was no lymphadenopathy, abdomen was
oft, spleen and liver were impalpable. Initial punch biopsy showed
ctinic keratosis with epithelial dysplasia. Therefore, a bigger and
eeper incisional biopsy was performed, which showed Lambda
ight chain monoclonal plasma cell inﬁltrate on immunostain.
Multiple myeloma screen followed. Results showed normal full
lood count, renal proﬁle, liver function test, serum M protein, total
rotein, albumin, globulin, SFLC was high (43.04) so as KL ratio
1.971) and 2 microglobulin (4.4). IgG, IgA and IgM were all nor-
al. However, skeletal survey showed possible osteolytic lesions in
ifferent areas. The signiﬁcance of this was not determined at that
ime so it was decided to repeat the above tests regularly to monitor
he condition. Subsequent blood tests remains largely unchanged.
Earlier, the case was discussed at the MDT  meeting in our hos-
ital. The lesion in the scalp was excised under local anaesthetic
∗ Corresponding author at: The Princess Alexandra Hospital, Hamstel Road, CM20
QX, United Kingdom.
E-mail address: akeel.mosea@pah.nhs.uk (A. Mosea).
ttp://dx.doi.org/10.1016/j.ijscr.2016.02.016
210-2612/© 2016 The Authors. Published by Elsevier Ltd. on behalf of IJS Publishing Gro
http://creativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
(Fig. 1), the defect was repaired with a full thickness skin graft from
the shoulder.
Deﬁnitive pathology conﬁrmed a completely excised
IgA/Lambda plasmacytoma with adjacent Bowenoid actinic
keratosis (Fig. 2).
The patient had wound infection following the surgery, and he
regularly attended wound dressing clinics. He remains well in him-
self sixteen months since the lesion started, with no evidence of
recurrent disease or systemic involvement.
2. Discussion
Plasma cells are produced in the bone marrow and are found in
the blood, skin and throughout the body. Plasma cell tumours have
been reported over 100 years ago. Five types of which have been
described: multiple myeloma (MM),  soliatry myeloma (plasmacy-
toma of bone), extramedullary plasmacytoma (EMP) and plasma
cell leukaemia.
EMP  applies to monoclonal proliferation of plasma cells outside
the bone marrow. The upper airway passage is the most common
site for EMP  [1,2].
Cutaneous extra medullary plasmacytoma (cEMP) without evi-
dence of bone marrow involvement (primary cEMP) is very rare
[2,3]. They usually present as a solitary or multiple red nodule or a
dome shaped skin elevation which may  ulcerate [3–6].
EMP  in general occurs between the fourth and the seventh
decade of life and is more common in men  [1–4]. Cutaneous
involvement in a patient with MM  (secondary cEMP) indicates
up Ltd. This is an open access article under the CC BY-NC-ND license
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mFig. 1. Excised lesion.
ncreased tumour burden in the body, hence an ominous sign. On
he other hand, primary cEMP has a much more favourable outcome
2,3]. The size of the tumour and the clinical presentation (soli-
ary vs multiple lesions) are the main prognostic factors in primary
EMP [4,6].
According to the International Myeloma Working Group [7],
rimary cEMP can be diagnosed by showing monoclonality of the
lasma cells aggregate on immunohistochemical studies, absence
f M-protein in serum and/or urine (although a small M-component
ay  sometimes be present), normal bone marrow, normal skeletal
urvey and no related end organ damage.
Solitary primary cEMP may  be treated conservatively by surgical
xcision with/out local radiotherapy [3,6,8].
. Could have Bowens disease in our case contributed to
he development of the plasma cell tumour?
Skin malignancy arising from sites of trauma, irritation, burns
nd old scars is a well known phenomenon ﬁrst described in 1828.
arjolin’s ulcers represent malignant degeneration arising in a pre
xisting scar tissues, mainly old burn scars. These are usually squa-
ous cell tumours but can be basal cell or melanoma [9].
Fig. 2. Histology andPEN  ACCESS
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Wiltshaw [1] explained the predilection of EMP  for the sub-
mucosal tissue of the upper airways passages to recurrent local
infections. Also implantation of foreign materials in susceptible
animals can induce EMP  in the affected animal [1].
Cases of cutaneous plasmacytoma developing in sites of local
trauma have been described in literature [8,10,11]. Most of these
tumours arise from the scars of previous surgery in patients with
multiple myeloma (secondary cEMP) [10,11]. It is thought that
plasma cells expressing CXCR4 cytokine receptor can interact with
the inﬂammatory cascade released due to tissue injury, facilitating
the migration neoplastic plasma cells into the skin [11,12].
Li et al. [8] reported a case of primary cEMP developing over the
pacemaker implantation site one year after insertion. Initial inves-
tigations ruled out MM in that patient. The lesion was treated with
radiotherapy after extraction of the pacemaker and the implanta-
tion of a new one on the opposite site. The patient subsequently
developed additional cutaneous plasmacytoma over the new pace-
maker insertion site and eventually died of progressive MM.
One can argue that the existence of Bowens actinic keratosis
immediately adjacent to the plasma cell tumour in our case was
a mere co-incidence, as this type of keratosis is common over sun
exposed sites like the scalp. However, the irritation and skin inﬂam-
mation associated with Bowens disease with all the surrounding
ulceration and scarring could have had a tropical effect in attracting
neoplastic plasma cells from the blood or bone marrow (secondary
cEMP) or promoting neoplastic monoclonality of a local plasma cell
population if there was  no MM in the background (primary cEMP).
Further research is needed to verify this hypothesis.
4. Method
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